Biotech & Pharma News & Analysis | Business 2.0
EMBL, MOLIT: EMBRACE Links Organoids and AI for Precision-Medicine Research
Johnson & Johnson Reports ICOTYDE Psoriasis Trial Meets Main Endpoints
GSK Sets Out Liver Disease Research for AASLD
EMBL Explores Brain Cancer Cell States With AI and Single-Cell Technologies
Can In Vivo CAR-T Simplify Cell Therapy Manufacturing?
EMBL Images Ribosome Assembly Inside Human Cells
Ris-Rez Shows Progression-free Survival Gain in ARTEMIS-011 Osteosarcoma Trial
Johnson & Johnson Details Head and Neck Tumour Responses in OrigAMI-4
GSK Announces US Approval of Hibsago for Selected Hepatitis B Patients
Jemperli Gains US Accelerated Approval for MSI-H/dMMR Rectal Cancer
GSK Reports Early Global Lung Cancer Results for Ris-Rez
AlphaGenome Can Rank Variants Fast but Validation Still Decides
Johnson & Johnson Lifts 2026 Sales Guidance as Innovative Medicine Leads
How Synthetic Cells Could Reshape Drug Discovery With Genomics and AI
GSK Unit's Long-acting HIV Regimen Meets Phase Iiib Endpoint
Alexion to Present 16 Rare Disease Studies at ASBMR 2026
Astrazeneca Opens Kendall Square R&d Centre With $1 Billion Bet
Bayer Plans 2.2 Billion Dollar Ohio Manufacturing Site
Top 10 Biopharma Conferences In London, UK And Europe In 2026-2027 And 2027
Astrazeneca, Daiichi Sankyo Add Summit to Datroway Combination Push